| pubmed-article:19147461 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19147461 | lifeskim:mentions | umls-concept:C0239307 | lld:lifeskim |
| pubmed-article:19147461 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:19147461 | lifeskim:mentions | umls-concept:C0162791 | lld:lifeskim |
| pubmed-article:19147461 | lifeskim:mentions | umls-concept:C0007189 | lld:lifeskim |
| pubmed-article:19147461 | lifeskim:mentions | umls-concept:C0034036 | lld:lifeskim |
| pubmed-article:19147461 | lifeskim:mentions | umls-concept:C0264716 | lld:lifeskim |
| pubmed-article:19147461 | lifeskim:mentions | umls-concept:C1273870 | lld:lifeskim |
| pubmed-article:19147461 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:19147461 | pubmed:dateCreated | 2009-1-16 | lld:pubmed |
| pubmed-article:19147461 | pubmed:abstractText | Recent studies have shown that prescription rates and doses of recommended drugs for chronic heart failure (CHF) are not optimal in daily practice. The aim of the Impact-Reco programme was to analyse prescription rates of CHF drugs in stable outpatients with CHF related to left ventricular (LV) systolic dysfunction in two similar surveys in France. | lld:pubmed |
| pubmed-article:19147461 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19147461 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19147461 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19147461 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19147461 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19147461 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19147461 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19147461 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19147461 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19147461 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:19147461 | pubmed:issn | 1388-9842 | lld:pubmed |
| pubmed-article:19147461 | pubmed:author | pubmed-author:GalinierMiche... | lld:pubmed |
| pubmed-article:19147461 | pubmed:author | pubmed-author:KomajdaMichel... | lld:pubmed |
| pubmed-article:19147461 | pubmed:author | pubmed-author:JondeauGuilla... | lld:pubmed |
| pubmed-article:19147461 | pubmed:author | pubmed-author:de... | lld:pubmed |
| pubmed-article:19147461 | pubmed:author | pubmed-author:IsnardRichard... | lld:pubmed |
| pubmed-article:19147461 | pubmed:author | pubmed-author:ClersonPierre... | lld:pubmed |
| pubmed-article:19147461 | pubmed:author | pubmed-author:DucardonnetAl... | lld:pubmed |
| pubmed-article:19147461 | pubmed:author | pubmed-author:AssyagPatrick... | lld:pubmed |
| pubmed-article:19147461 | pubmed:author | pubmed-author:DemilNacimaN | lld:pubmed |
| pubmed-article:19147461 | pubmed:author | pubmed-author:ThebautJean-F... | lld:pubmed |
| pubmed-article:19147461 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:19147461 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:19147461 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19147461 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19147461 | pubmed:pagination | 85-91 | lld:pubmed |
| pubmed-article:19147461 | pubmed:dateRevised | 2011-6-8 | lld:pubmed |
| pubmed-article:19147461 | pubmed:meshHeading | pubmed-meshheading:19147461... | lld:pubmed |
| pubmed-article:19147461 | pubmed:meshHeading | pubmed-meshheading:19147461... | lld:pubmed |
| pubmed-article:19147461 | pubmed:meshHeading | pubmed-meshheading:19147461... | lld:pubmed |
| pubmed-article:19147461 | pubmed:meshHeading | pubmed-meshheading:19147461... | lld:pubmed |
| pubmed-article:19147461 | pubmed:meshHeading | pubmed-meshheading:19147461... | lld:pubmed |
| pubmed-article:19147461 | pubmed:meshHeading | pubmed-meshheading:19147461... | lld:pubmed |
| pubmed-article:19147461 | pubmed:meshHeading | pubmed-meshheading:19147461... | lld:pubmed |
| pubmed-article:19147461 | pubmed:meshHeading | pubmed-meshheading:19147461... | lld:pubmed |
| pubmed-article:19147461 | pubmed:meshHeading | pubmed-meshheading:19147461... | lld:pubmed |
| pubmed-article:19147461 | pubmed:meshHeading | pubmed-meshheading:19147461... | lld:pubmed |
| pubmed-article:19147461 | pubmed:meshHeading | pubmed-meshheading:19147461... | lld:pubmed |
| pubmed-article:19147461 | pubmed:meshHeading | pubmed-meshheading:19147461... | lld:pubmed |
| pubmed-article:19147461 | pubmed:meshHeading | pubmed-meshheading:19147461... | lld:pubmed |
| pubmed-article:19147461 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19147461 | pubmed:articleTitle | Improvement in the management of chronic heart failure since the publication of the updated guidelines of the European Society of Cardiology. The Impact-Reco Programme. | lld:pubmed |
| pubmed-article:19147461 | pubmed:affiliation | Pôle de Cardiologie et Maladies Vasculaires, CHRU de Lille, Université de Lille 2, France. | lld:pubmed |
| pubmed-article:19147461 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19147461 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19147461 | lld:pubmed |
